Clinical Trial Update: Trial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Colds Due to Enterovirus/Rhinovirus Infection [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating nitazoxanide for treatment of colds caused by enterovirus or rhinovirus was terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Common Cold
• Enterovirus Infection
• Rhinovirus Infection

Drugs mentioned

• Nitazoxanide (nitazoxanide)

Snippet

Sponsor: Romark Laboratories L.C. | Conditions: Enterovirus, Rhinovirus | Phase 3 | Status: TERMINATED | Results posted: 2024-10-17